These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32964035)

  • 1. SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.
    Hong W; Yu S; Zhuang Y; Zhang Q; Wang J; Gao X
    Biomed Res Int; 2020; 2020():5307641. PubMed ID: 32964035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
    Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
    Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.
    Ye L; Wang H; Liu B
    Tumour Biol; 2016 Jan; 37(1):1151-7. PubMed ID: 26277787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
    Cao M; Hou D; Liang H; Gong F; Wang Y; Yan X; Jiang X; Wang C; Zhang J; Zen K; Zhang CY; Chen X
    Eur J Cancer; 2014 Mar; 50(5):1013-24. PubMed ID: 24456795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.
    Wu W; He L; Huang Y; Hou L; Zhang W; Zhang L; Wu C
    Oncol Res; 2019 Aug; 27(8):879-887. PubMed ID: 30982489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
    Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
    Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA TPTEP1 competitively sponges miR‑328‑5p to inhibit the proliferation of non‑small cell lung cancer cells.
    Cao F; Wang Z; Feng Y; Zhu H; Yang M; Zhang S; Wang X
    Oncol Rep; 2020 May; 43(5):1606-1618. PubMed ID: 32323798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.
    Chen B; Pan W; Lin X; Hu Z; Jin Y; Chen H; Ma G; Qiu Y; Chang L; Hua C; Zou Y; Gao Y; Ying H; Lv D
    Tumour Biol; 2016 Feb; 37(2):2765-71. PubMed ID: 26408183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2.
    Wang L; Ma H; Kong W; Liu B; Zhang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31076544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-induced upregulation of circCCDC66 facilitates the progression of non-small cell lung cancer by targeting miR-33a-5p/KPNA4 axis.
    Wang Y; Zhao W; Zhang S
    Biomed Pharmacother; 2020 Jun; 126():110019. PubMed ID: 32151944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circCCDC66 promotes glioma proliferation by acting as a ceRNA for miR-320a to regulate FOXM1 expression.
    Qi L; Wang W; Zhao G; Jiang H; Zhang Y; Zhao D; Jin H; Xu H; Yu H
    Aging (Albany NY); 2021 Jul; 13(13):17673-17689. PubMed ID: 34252882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
    Yang F; Luo LJ; Zhang L; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2017 Feb; 600():21-28. PubMed ID: 27913185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.
    Yang H; Zhao M; Zhao L; Li P; Duan Y; Li G
    Cell Oncol (Dordr); 2020 Jun; 43(3):477-488. PubMed ID: 32297303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
    Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
    J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
    Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1.
    Zhang L; Lin J; Ye Y; Oba T; Gentile E; Lian J; Wang J; Zhao Y; Gu J; Wistuba II; Roth JA; Ji L; Wu X
    Clin Pharmacol Ther; 2018 Jun; 103(6):1061-1073. PubMed ID: 28891208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.